[2] World Health Organization. (2010) Epilepsy in The WHO European Region: Fostering Epilepsy Care in Europe. Cruquius, Paswerk Bedrijven. Available from: www.ibe-epilepsy.org/downloads/EURO%20Report%20160510.pdf [http://www.ibe-epilepsy.org/downloads/EURO%20Report%20160510... ] [Accessed August 2017].
[3] World Health Organization. (2017) Epilepsy Fact Sheet. Available from: www.who.int/mediacentre/factsheets/fs999... [http://www.who.int/mediacentre/factsheet... ][Accessed August 2017].
[4] Eisai. (2017) Zebinix(R) (eslicarbazepine acetate) Summary of Product Characteristics. Available from: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product... 88/WC500047225.pdf [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_... ] [Accessed August 2017].
[5] Hebeisen S, et al. (2015) Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide. Neuropharmacology. 89, 122-135
[6] Elger C, et al. (2007) Eslicarbazepine acetate: A double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia. 48, 497-504.
[7] Elger C, et al. (2009) Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial onset seizures: A randomised, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia. 50, 454-63.
[8] Ben-Menachem E, et al. (2010) Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Research. 89(2-3), 278-85.
[9] Gil-Nagel A, et al. (2009) Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurologica Scandinavica. 120, 281-87.
August 2017 Zebinix-EU0144
CONTACT: Media Enquiries: Bial, Susana Vasconcelos,+35-1229-866-100/+35-1229-866-148, Susana.Vasconcelos@Bial.com; Eisai,Helena Symeou, +44-7505-309-895, Helena_Symeou@eisai.net; Tonic LifeCommunications, Callum Haire, +44-7867-429-637, Callum.Haire@toniclc.com
